ESC & iPSC News 14.03 January 30, 2019 | |
| |
TOP STORYScientists defined epigenomic landscape during epidermal differentiation of human PSCs and created inference networks that integrated gene expression, chromatin accessibility, and transcription factor binding to define regulatory mechanisms during keratinocyte specification. [Cell Stem Cell] Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Differentiation and Maturation of Oligodendrocytes in Human Three-Dimensional Neural Cultures Investigators developed a new differentiation method of human iPSCs to generate 3D brain organoids that contained oligodendrocytes as well as neurons and astrocytes, called human oligodendrocyte spheroids. [Nat Neurosci] Abstract | Press Release Researchers devised a nonadherent-suspension-shaking system to generate self-assembled embryo-like structures using mouse embryonic, trophoblast and extra-embryonic endoderm stem cells. When cultured together, the three cell types aggregated and sorted into lineage-specific compartments. [Nat Commun] Full Article Dppa2 and Dppa4 Directly Regulate the Dux-Driven Zygotic Transcriptional Program Through a combination of overexpression, knockdown, knockout, and rescue experiments together with transcriptional analyses, investigators showed that developmental pluripotency-associated 2 (Dppa2) and Dppa4 directly regulated the 2C-like cell population and associated transcripts, including Dux and the Zscan4 cluster. [Genes Dev] Abstract | Press Release | Full Article ESCs were first induced into primordial germ cell-like cells, which were further induced into male germline cells, including spermatogonial stem cell-like cells (SSCLCs) and spermatid-like cells. The obtained SSCLCs were functional as infertile male mice sired healthy offspring via SSCLC transplantation. [Cell Death Differ] Abstract The authors aimed to identify small molecule inducers of aldehyde dehydrogenase 1b1 (Aldh1b1) expression taking advantage of a mouse ES (mES) Aldh1b1 lacZ reporter cell line and a pancreas differentiation protocol directing mES cells into pancreatic progenitors. [Stem Cells] Abstract | Full Article Dynamic Methylation of an L1 Transduction Family during Reprogramming and Neurodifferentiation Scientists identified a de novo LINE-1 (L1) insertion in a human iPSC (hiPSC) line via retrotransposon capture (RC) sequencing. The L1 insertion was full-length and carried 5′ and 3′ transductions. The corresponding donor RC-L1 was part of a large and recently active L1 transduction family and was highly mobile in a cultured cell L1 retrotransposition reporter assay. [Mol Cell Biol] Abstract | Full Article The activity of the pathway was progressively silenced during passages in culture and this resulted in a loss of DNA methylation at many imprinting control regions, loss of recruitment of chromatin repressors, and activation of retrotransposons, resulting in impaired mouse ESC differentiation. [Sci Rep] Full Article The novel protocol successfully worked with different human (h) PSC lines including hESCs and hiPSCs maintained in two different stem cell media prior to differentiation. Definitive endoderm cells obtained by the novel BSA-free 3D protocol could be further differentiated into PDX1- or NKX6.1-expressing pancreatic progenitor cells. [Sci Rep] Full Article Targeted Gene Silencing in Human Embryonic Stem Cells Using Cell-Penetrating Peptide PepFect 14 Human ES cells were transfected in ROCK inhibitor containing medium for 24-hours right after EDTA passaging as small cell clumps. Fluorescently labeled siRNA and siRNAs targeting OCT4 or beta-2-microglobulin mRNA sequences were used to evaluate the efficiency of transfection and silencing. Analyses were performed at various time points by flow cytometry, RT-qPCR, and immunofluorescence microscopy. [Stem Cell Res Ther] Full Article Subscribe to one of our other 19 science newsletters such as Cell Therapy News & Mesenchymal Cell News. | |
| |
REVIEWSOpen Chromatin, Epigenetic Plasticity, and Nuclear Organization in Pluripotency The authors systematically review chromatin and epigenetic features in GSK3/MEK inhibitors- and serum-grown conditions to come to a clearer picture of what are genuine characteristics of pluripotency and what open chromatin features predict pluripotency. [Dev Cell] Abstract Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field. | |
| |
INDUSTRY NEWSAsterias Biotherapeutics, Inc. provided top-line 12 month data from the company’s Phase I/IIa SCiStar study designed to evaluate the safety and potential efficacy of OPC1 in the treatment of severe cervical spinal cord injury [Asterias Biotherapeutics, Inc.] Press Release Cellect Biotechnology Ltd. announced it has concluded the scale-up development and manufacturing of clinical grade FasL in collaboration with its outsourced supplier. The FasL protein is central to Cellect’s technology of cell separation and functional selection of stem cells and is the key active ingredient in Cellect’s ApoGraft™ and Apotainer product lines. [Cellect Biotechnology Ltd. (PR Newswire Association LLC.)] Press Release The Damon Runyon Cancer Research Foundation named 18 new Damon Runyon Fellows at its fall Fellowship Award Committee review. The recipients of this prestigious, four-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country. [Damon Runyon Cancer Research Foundation (EurekAlert!)] Editorial | |
| |
POLICY NEWSJapan Should Put the Brakes on Stem-Cell Sales Healing spinal-cord injuries has been one of the most difficult – and doggedly pursued – quests in medicine, and among the most symbolic goals for the field of stem cells and regenerative medicine. Progress, however, has been frustratingly slow. Dozens of seemingly promising efforts, based on animal studies, have fallen flat. [Nature News] Editorial The US Scientists Who Knew about CRISPRed Babies Multiple researchers were aware of He Jiankui’s clinical trial before the news became public in November. The most recent revelation came when the AP reported that He sent an email to University of Massachusetts professor Craig Mello in April 2018 in which he said a pregnancy had been achieved with the CRISPRed embryos. [The Scientist] Editorial
| |
EVENTSNEW The NYSCF Conference 2019 Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Research Fellow – Discovery Oncology (Merck) Research Technologist – Pluripotent Stem Cells (STEMCELL Technologies Inc.) Scientist – Cell Culture Media and Cell Line Development (STEMCELL Technologies Inc.) Postdoctoral Position – Stem Cells & Neurodegeneration (Lund University) Postdoctoral Fellow – Stem Cell Biology (City of Hope) Senior Laboratory Research Scientist – Pluripotent Stem Cell Research (The Francis Crick Institute) Postdoctoral Fellow – Genetics and Epigenomics of iPSC Biology (Stanford University) Assistant Associate Professor/Professor in Residence – Stem Cell Program (UC Davis Medical Center) Postdoctoral Fellows – Human iPSC Cell Differentiation Research (Boston Children’s Hospital) Assistant/Associate Adjunct Professor – Cardiovascular Medicine (UC Davis) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in ESC & iPSC News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|